Fe Absorption in Mother and Child Pairs From Wheat Fortified With Iron With and Without Phenolic Containing Beverages (Fe_Senegal)

November 27, 2015 updated by: Swiss Federal Institute of Technology

Evaluating the National Fortification Policy in Senegal Assessment of Iron Bio-availability in Mother and Child Pairs From Wheat Flour Fortified With Iron With and Without Phenolic Containing Beverages

In Senegal, iron deficiency affects 39% of and 82% of women and children between 12 and 50 months indicating that iron deficiency is a major health problem. The government of Senegal has implemented a flour fortification program including iron and folate. Iron is a difficult mineral to add to foods efficiently due to its organoleptic properties and typical low bioavailability in man. The aim of this study is to determine iron absorption from fortified wheat flour consumed with a phenolic containing beverage in women and child pairs. The fortificants used will be Ferrous Fumarate and Ferrous Sulfate, and the effect of absorption inhibitors on the bioavailability from iron compounds not readily bioavailable is poorly investigated.

The bioavailability of the different iron compounds will be determined using stable iron isotopes. Sixteen pairs of women and children (n=34, children between 3-6 years, women between 18-45y) will be selected for participation in the study. After a screening, each women and child will receive 4 test meals consisting of a bread roll fortified stable isotopes with and without the tisane beverage. The first two test meals will be consumed on consecutive days. Two weeks after the second test meal a blood sample will be taken from each women and child before the third meal administration. After the forth test meal administration, and again two weeks later, the last blood sampling will take place and the study will be conducted for the subjects (duration 30 days). The samples will be sent to Zurich on dry ice for analysis for the following parameters: isotopic composition, H pylori infection, B vitamin status, Vitamin A status. In all samples, hemoglobin and iron status as well as inflammation status (CRP) will be determined.

Study Overview

Detailed Description

In this study each subject will act as his own control and receive all interventions. Iron absorption data from the different test meals will be therefore compared assessing within and subject effects (main outcomes). Secondary outcomes will also investigate between subject effects and co variates of iron absorption.

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dakar, Senegal
        • Université Cheikh Anta Diop

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 50 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria

  • Mother and child are willing to participate in the study jointly

Specific inclusions criteria for mothers

  • Body weight < 65 kg
  • 17 ≤ BMI ≤ 25 (kg/m2)
  • Non anemic (Hb ≥ 11,0 g/dl)
  • Generally healthy and no chronic illnesses
  • Non pregnant
  • Non lactating
  • No blood donation in the last 4 months
  • No consumption of vitamin and nutritional supplements during and 2 weeks prior the study start.

Inclusion criteria for children:

  • Age 3-6 years
  • Generally healthy and no chronic illnesses
  • no consumption of vitamin and mineral supplements during and 2 weeks prior the study start

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: FESO4+T
Ferrous sulfate fortified bread with tea
Fasting subjects will be served a wheat roll fortified with labelled ferrous sulfate and stable isotopes
Experimental: FESO4+W
Ferrous sulfate fortified bread with water
Fasting subjects will be served a wheat roll fortified with labelled ferrous sulfate and stable isotopes
Experimental: FeFu+T
Ferrous fumarate fortified bread with tea
Fasting subjects will be served a wheat roll fortified with labelled Fe Fumarate and stable isotopes
Experimental: FeFu+W
Ferrous fumarate fortified bread with water
Fasting subjects will be served a wheat roll fortified with labelled Fe Fumarate and stable isotopes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Iron absorption measured as iron incorporation of stable isotopic labels in red blood cells 14 days after administration
Time Frame: Up to 8 Months after study start
The effect of the consumption of tea (phenolic containing beverages) will be assessed the two iron fortification compounds. The interaction between beverage and compound on iron absorption will be tested. The analysis will be separately conducted for mothers and children.
Up to 8 Months after study start

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between iron absorption in mother and child pairs
Time Frame: Up to 8 Months after study start
The correlation of iron absorption from the different test meals between in mother and child pairs will be assessed. A variable will be defined which will consist of the difference in iron absorption between each mother and child, within one mother child pair cluster. Determinants of this variable will be explored by linear regression, such as iron status, parity, age, gender, anthropometry, iron status, vitamin status (A, B2, B12, folate) h. pylori test and hepcidin.
Up to 8 Months after study start

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ndeye Fatou Ndiaye, PhD, Université Cheikh Anta Diop de Dakar, Sengal

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2015

Primary Completion (Actual)

June 1, 2015

Study Completion (Actual)

October 1, 2015

Study Registration Dates

First Submitted

April 15, 2015

First Submitted That Met QC Criteria

May 5, 2015

First Posted (Estimate)

May 8, 2015

Study Record Updates

Last Update Posted (Estimate)

November 30, 2015

Last Update Submitted That Met QC Criteria

November 27, 2015

Last Verified

November 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • EK 2014-N-37

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anemia; Deficiency, Nutritional, With Poor Iron Absorption

Clinical Trials on Ferrous sulfate fortified bread with tea

Subscribe